In yesterday’s Wall Street session, Healthcare Realty Trust Inc (NYSE:HR) shares traded at $17.30, down -2.81% from the previous session.
HR stock price is now -2.44% away from the 50-day moving average and 6.28% away from the 200-day moving average. The market capitalization of the company currently stands at $5.96B.
With the price target reduced from $17 to $16, Wells Fargo Downgraded its rating from Equal Weight to Underweight for Healthcare Realty Trust Inc (NYSE: HR). On February 20, 2024, Wedbush Downgraded its previous ‘Outperform’ rating to ‘Neutral’ on the stock reducing its target price from $19 to quote $15, while ‘Stifel’ rates the stock as ‘Hold’
In other news, Bohjalian Thomas N, Director bought 4,000 shares of the company’s stock on Nov 22 ’24. The stock was bought for $68,800 at an average price of $17.20. Upon completion of the transaction, the Director now directly owns 54,002 shares in the company, valued at $0.93 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 22 ’24, Director Bohjalian Thomas N bought 7,750 shares of the business’s stock. A total of $134,795 was incurred on buying the stock at an average price of $17.39. This leaves the insider owning 50,002 shares of the company worth $0.87 million. A total of 0.80% of the company’s stock is owned by insiders.
During the past 12 months, Healthcare Realty Trust Inc has had a low of $12.77 and a high of $18.90. The fifty day moving average price for HR is $17.7318 and a two-hundred day moving average price translates $16.27825 for the stock.
The latest earnings results from Healthcare Realty Trust Inc (NYSE: HR) was released for 2024-09-30. The net profit margin was -46.11% and return on equity was -9.49% for HR. The company reported revenue of $315.42 million for the quarter, compared to $342.26 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -7.84 percent.
